sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 7, 2025

Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa

View original at globenewswire.com
Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa LONDON, Ontario, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Europe opens unique opportunities to strengthen collaboration along the entire value chain

    80% confidence
  • Using a brownfield site reduces project risk and capital requirements by simplifying integration of permits, land use plans, and utilities while achieving operational readiness faster

    80% confidence
  • The approach reflects the adaptability of Hydrochemolytic Technology to existing industrial facilities where conventional thermal systems can be modernized with water-based chemistry at lower temperatures, leveraging benefits of existing infrastructure and supply chains

    80% confidence
  • The fact that the region hosts a multitude of chemical industry producers, processors, and recycling companies provides a solid foundation for expanding collaboration with potential partners and customers

    80% confidence
  • The property has potential for future expansion to capacity of up to 25,000 tonnes per year

    80% confidence
  • The company expects to make a final site decision in January 2026

    80% confidence
  • This structured approach reduces execution risk and continues to focus on process integration, performance validation, and customer engagement

    80% confidence
  • The team is applying the same disciplined approach used in developing the NGP pilot plant, seeking a site that meets rigorous evaluation standards while keeping options open for future commercial-scale expansion

    80% confidence
  • The LOI is another important step on the path from pilot to demonstration plant and ultimately to commercialization

    80% confidence
  • Establishing a demonstration plant in the Netherlands will help validate performance at scale and accelerate processes that turn technical success into commercial application

    80% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · demonstration plant capacity25000 tonnes_per_year
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa — Source | Via News | pt.VIA.NEWS